214 related articles for article (PubMed ID: 28747219)
1. Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report.
Facchini L; Lucchesi M; Stival A; Roperto RM; Melosi F; Materassi M; Farina S; Tintori V; de Martino M; Sardi I
J Med Case Rep; 2017 Jul; 11(1):209. PubMed ID: 28747219
[TBL] [Abstract][Full Text] [Related]
2. Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre.
Grall M; Daviet F; Chiche NJ; Provot F; Presne C; Coindre JP; Pouteil-Noble C; Karras A; Guerrot D; François A; Benhamou Y; Veyradier A; Frémeaux-Bacchi V; Coppo P; Grangé S
BMC Nephrol; 2021 Jul; 22(1):267. PubMed ID: 34284729
[TBL] [Abstract][Full Text] [Related]
3. Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature.
Burns ST; Damon L; Akagi N; Laszik Z; Ko AH
Anticancer Res; 2020 Jul; 40(7):3995-4000. PubMed ID: 32620643
[TBL] [Abstract][Full Text] [Related]
4. The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
Krishnappa V; Gupta M; Shah H; Das A; Tanphaichitr N; Novak R; Raina R
BMC Nephrol; 2018 Jan; 19(1):9. PubMed ID: 29329518
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic Microangiopathy in a Patient Treated With Gemcitabine.
Nanjappa S; Singh V; Uttamchandani S; Pabbathi S
Cancer Control; 2017 Jan; 24(1):54-56. PubMed ID: 28178713
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports
.
López Rubio ME; Rodado Martínez R; Illescas ML; Mateo Bosch E; Martinez Díaz M; de la Vara Inesta L; Cabezuelo B; Morales Albuja ME; Lucas Guillén E; Jimeno García L
Clin Nephrol; 2017 Feb; 87 (2017)(2):100-106. PubMed ID: 27879189
[TBL] [Abstract][Full Text] [Related]
7. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
Saif MW; McGee PJ
JOP; 2005 Jul; 6(4):369-74. PubMed ID: 16006690
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report].
Rogier T; Gerfaud-Valentin M; Pouteil-Noble C; Taleb A; Guillet M; Noel A; Broussolle C; Sève P
Rev Med Interne; 2016 Oct; 37(10):701-704. PubMed ID: 26833144
[TBL] [Abstract][Full Text] [Related]
9. Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab.
Gourley BL; Mesa H; Gupta P
Cancer Chemother Pharmacol; 2010 Apr; 65(5):1001-4. PubMed ID: 20119714
[TBL] [Abstract][Full Text] [Related]
10. [Hemolytic-uremic syndrome complicating a long-term treatment with gemcitabine. Report of a case and review of the literature].
Dilhuydy MS; Delclaux C; Pariente A; De Precigout V; Aparicio M
Rev Med Interne; 2002 Feb; 23(2):189-92. PubMed ID: 11876063
[TBL] [Abstract][Full Text] [Related]
11. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
[TBL] [Abstract][Full Text] [Related]
12. [Hemolytic-uremic syndrome associated with gemcitabine use: report of one case].
Vega J; Parodi C; Méndez GP; Goecke H
Rev Med Chil; 2013 Jun; 141(6):797-802. PubMed ID: 24121585
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
Flombaum CD; Mouradian JA; Casper ES; Erlandson RA; Benedetti F
Am J Kidney Dis; 1999 Mar; 33(3):555-62. PubMed ID: 10070921
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
[TBL] [Abstract][Full Text] [Related]
15. [A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine].
Eckel F; Lersch C; Erdmann J; Schmidt B; Schulte-Frohlinde E
Z Gastroenterol; 2000 Jul; 38(7):593-6. PubMed ID: 10965557
[TBL] [Abstract][Full Text] [Related]
16. Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma.
Nieto-Ríos JF; Zuluaga-Quintero M; Higuita LM; Rincón CI; Galvez-Cárdenas KM; Ocampo-Kohn C; Aristizabal-Alzate A; Florez-Vargas AA; Zuluaga-Valencia GA
J Bras Nefrol; 2016 Jun; 38(2):255-9. PubMed ID: 27438981
[TBL] [Abstract][Full Text] [Related]
17. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM; Licht C; Muus P; Greenbaum LA; Babu S; Bedrosian C; Bingham C; Cohen DJ; Delmas Y; Douglas K; Eitner F; Feldkamp T; Fouque D; Furman RR; Gaber O; Herthelius M; Hourmant M; Karpman D; Lebranchu Y; Mariat C; Menne J; Moulin B; Nürnberger J; Ogawa M; Remuzzi G; Richard T; Sberro-Soussan R; Severino B; Sheerin NS; Trivelli A; Zimmerhackl LB; Goodship T; Loirat C
N Engl J Med; 2013 Jun; 368(23):2169-81. PubMed ID: 23738544
[TBL] [Abstract][Full Text] [Related]
18. [Gemcitabine-induced thrombotic microangiopathy: Can we improve screening and treatment?].
Charmetant X; Jolivot A; Fournier T; Puthet JC; Cassier P; Lemoine S; Juillard L
Nephrol Ther; 2017 Jun; 13(4):251-254. PubMed ID: 28499586
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy.
Lhotta K; Kühr T; Rumpelt HJ; Wöll E; Thaler J; König P
Am J Nephrol; 1999; 19(5):590-3. PubMed ID: 10575189
[TBL] [Abstract][Full Text] [Related]
20. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.
Giordano P; Netti GS; Santangelo L; Castellano G; Carbone V; Torres DD; Martino M; Sesta M; Di Cuonzo F; Resta MC; Gaeta A; Milella L; Chironna M; Germinario C; Scavia G; Gesualdo L; Giordano M
Pediatr Nephrol; 2019 Mar; 34(3):517-527. PubMed ID: 30362078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
